Chaim Hurvitz - Net Worth and Insider Trading
Chaim Hurvitz Net Worth
The estimated net worth of Chaim Hurvitz is at least $465,106 dollars as of 2024-05-05. Chaim Hurvitz is the Director of NRX Pharmaceuticals Inc and owns about 221,479 shares of NRX Pharmaceuticals Inc (NRXP) stock worth over $465,106. Details can be seen in Chaim Hurvitz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Chaim Hurvitz has not made any transactions after 2023-08-30 and currently still holds the listed stock(s).
Transaction Summary of Chaim Hurvitz
Chaim Hurvitz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chaim Hurvitz owns 2 companies in total, including NRX Pharmaceuticals Inc (NRXP) , and Dror Ortho-Design Inc (DROR) .
Click here to see the complete history of Chaim Hurvitz’s form 4 insider trades.
Insider Ownership Summary of Chaim Hurvitz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NRXP | NRX Pharmaceuticals Inc | 2023-08-30 | director |
| DROR | Dror Ortho-Design Inc | 2023-08-14 | director |
Chaim Hurvitz Latest Holdings Summary
Chaim Hurvitz currently owns a total of 1 stock. Chaim Hurvitz owns 221,479 shares of NRX Pharmaceuticals Inc (NRXP) as of August 30, 2023, with a value of $465,106.
Latest Holdings of Chaim Hurvitz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals Inc | 2023-08-30 | 221,479 | 2.10 | 465,106 |
Holding Weightings of Chaim Hurvitz
Chaim Hurvitz Form 4 Trading Tracker
According to the SEC Form 4 filings, Chaim Hurvitz has made a total of 3 transactions in NRX Pharmaceuticals Inc (NRXP) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in NRX Pharmaceuticals Inc is the acquisition of 7,000 shares on August 30, 2023, which cost Chaim Hurvitz around $20,300.
Insider Trading History of Chaim Hurvitz
- 1
Chaim Hurvitz Trading Performance
GuruFocus tracks the stock performance after each of Chaim Hurvitz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chaim Hurvitz is 1.09%. GuruFocus also compares Chaim Hurvitz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chaim Hurvitz within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chaim Hurvitz's insider trading performs compared to the benchmark.
Performance of Chaim Hurvitz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.41 | | | | | |
| Relative Return to S&P 500(%) | -1.83 | | | | | |
Chaim Hurvitz Ownership Network
Chaim Hurvitz Owned Company Details
What does NRX Pharmaceuticals Inc do?
Who are the key executives at NRX Pharmaceuticals Inc?
Chaim Hurvitz is the director of NRX Pharmaceuticals Inc. Other key executives at NRX Pharmaceuticals Inc include Interim CFO Richard Clavano Narido , director & 10 percent owner & Chief Scientist Jonathan C Javitt , and director & Chief Executive Officer Stephen H Willard .
NRX Pharmaceuticals Inc (NRXP) Insider Trades Summary
Over the past 18 months, Chaim Hurvitz made 3 insider transaction in NRX Pharmaceuticals Inc (NRXP) with a net purchase of 1,070,000. Other recent insider transactions involving NRX Pharmaceuticals Inc (NRXP) include a net sale of 238,108 shares made by Daniel C. Javitt , a net sale of 100,000 shares made by Jonathan C Javitt , and a net purchase of 62,674 shares made by Voorhees Seth Van .
In summary, during the past 3 months, insiders sold 0 shares of NRX Pharmaceuticals Inc (NRXP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 63,811 shares of NRX Pharmaceuticals Inc (NRXP) were sold and 152,942 shares were bought by its insiders, resulting in a net purchase of 89,132 shares.
NRX Pharmaceuticals Inc (NRXP)'s detailed insider trading history can be found in Insider Trading Tracker table.
NRX Pharmaceuticals Inc Insider Transactions
Chaim Hurvitz Mailing Address
Above is the net worth, insider trading, and ownership report for Chaim Hurvitz. You might contact Chaim Hurvitz via mailing address: C/o Galmed Pharmaceuticals Ltd., 8 Shaul, Hamelech Blvd, Amot Hamishpat Bldg., Tel Aviv L3 64733.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
